Healthcare -
Biotechnology - NASDAQ - US
$ 20.905
-4.13 %
$ 1.03 B
Market Cap
-11.13
P/E
ELVN - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities ELVN - Enliven Therapeutics, Inc.
-36 M
LAST VALUE
-666.93%
2 YEAR CAGR
-8.39%
5 YEAR CAGR
0.00%
10 YEAR CAGR